TTS 2024 Plenary Speakers Update

David A. D’Alessandro,

Massachusetts General Hospital, Harvard Medical School, United States
Innovations to improve and transform patient-important outcomes in cardiac transplantation

Zofeen T. Ebrahim

Independent freelance journalist based in Karachi, Pakistan
Through the Lens: A Journalist's perspective and experience in raising awareness on organ donation and transplantation

Michelle A. Josephson

University of Chicago, Medical Director, Kidney Transplant, United States
Pregnancy in Solid Organ Transplant Recipients – current recommendations and controversies

Henry Marsh

Neurosurgeon and pioneer of awake craniotomy techniques, Co-founder of the charity Hospice Ukraine, United Kingdom

Ruth Sapir-Pichhadze

McGill University, Division of experimental medicine, Canada
Embracing Equity, Diversity & Inclusion Principles to Improve Access and Outcomes of Solid Organ Transplantation

TTS Leadership ESOT 2023 in Athens - Sept 17-20

If you're planning to participate in ESOT, be sure to mark your calendar for our leadership's presentations during the event. Don't miss the chance to join their sessions and introduce yourself!

Elmi Muller, TTS President

Breaking down barriers
Tue - 19 Sept @14:45 - Storytelling - I did it my way. How did I get here?

Vivek Kute, TTS Councilor

Kidney Paired Exchange - India
Sun - 17 Sept @17:45 - ESOT – ISOT joint session: Expanding living donor pool in kidney transplant

Dorry Segev, TTS Councilor

Can AI better address the gap between supply and demand?
Mon - 18 Sept @15:10 - Plenary - Overcoming the organ shortage: Thinking outside the box
The environmental impact of telemedicine
Tue - 19 Sept @10:40- Fishbowl - Digital interface with patients – outpatients in the 22nd century

Marcelle McPhaden, TTS Executive Director

We're pleased to share that Marcelle McPhaden, our Executive Director, will also be in attendance. Feel free to initiate a conversation with her – she's looking forward to connecting with you!

New Meeting Announcement - Nov 29-30, 2023

New Meeting Announcement - Dec 5-7, 2023

The event will be in a hybrid format, with the in-person component in Montréal, QC, on December 5-7, 2023. The organizers are delighted to announce that this year’s Meeting Co-Chairs are Dr. Siba Haykal and Dr. Vanessa Silva e Silva, supported by a planning committee of CDTRP researchers, trainees, and patient, family, and donor partners.

Transplantation Journal Highlights

Transplantation - Highlighted Tweets

Human A2-CAR T Cells Reject HLA-A2+ Human Islets Transplanted Into Mice Without Inducing Graft-versus-host Disease
Type 1 diabetes is an autoimmune disease characterized by T-cell–mediated destruction of pancreatic beta-cells. Islet transplantation is an effective therapy, but its success is limited by islet quality and availability along with the need for immunosuppression. New approaches include the use of stem cell–derived insulin-producing cells and immunomodulatory therapies, but a limitation is the paucity of reproducible animal models in which interactions between human immune cells and insulin-producing cells can be studied without the complication of xenogeneic graft-versus-host disease (xGVHD).
Obesity and Kidney Transplantation—How to Evaluate, What to Do, and Outcomes
Obesity is a growing issue that is spreading worldwide; its prevalence is ever increasing in patients with end-stage renal disease and represents a potential barrier to transplantation. The lack of unanimous guidelines exacerbates the current disparity in treatment, which can affect outcomes, leading to a significantly longer time on the waiting list. Multidisciplinary and multimodal management (encompassing several healthcare professionals such as nephrologists, transplant physicians and surgeons, primary care providers, and nurses) is of paramount importance for the optimal management of this patient population in a continuum from waitlisting to transplantation.

Transplantation Direct - Highlighted Tweets

Development of Bilateral Renal Cell Carcinoma in the Birt-Hogg-Dubé Syndrome Before and After Living-Related Kidney Transplantation
The Birt-Hogg-Dubé (BHD) syndrome is a rare, inherited, autosomal dominant disorder that was first described by Birt et al in 1977. It is characterized by cutaneous lesions on the face and neck, multiple pulmonary cysts, and renal cell carcinomas (RCCs). Furthermore, renal “oncocytosis” is a specific feature of patients with BHD syndrome; these nodules are presumed to be precursor lesions to malignant tumors. Renal lesions are the major cause of morbidity and mortality in BHD syndrome, and their diagnosis and management are crucial. Herein, we report a case of BHD syndrome with RCC development before and after living-related kidney transplantation. To our knowledge, this is the first report of BHD syndrome in a recipient of kidney transplantation.
Donor-derived Transmission of Hepatitis A Virus Following Kidney Transplantation: Clinical Course of Two Cases From One Donor
Donor-derived transmission of infections is a rare complication of kidney transplant. Hepatitis A virus (HAV) is a common cause of acute viral hepatitis worldwide, but donor-derived transmission to organ recipients has been reported in the literature only twice previously. The timeline for HAV incubation and clearance in transplant recipients is not well understood.

ISODP 2023 ... Registration is still open - Register today!

IPITA-IXA-CTRMS 2023 - Amazing Program!

Reminder 2023 Proposed TTS By-law Changes

Deadline to submit your ballot is September 21, 2023

TTS Council is pleased to present eight proposed By-law amendments to aid in shaping the future of the Society.

Among the changes proposed are expansion of Council to increase diversity, ensuring female, early career and Middle East AND Africa countries representation. TTS encourages all full members to actively participate by voting before the ballot closes September 21. To review the proposed by-law amendments and the rationale statements please click the link below.

If you are a TTS full member you should have received an e-mail with your personalized voting link today. Alternatively you may use the link above to submit your ballot.

TTS-ISN Sister Centers Application Submission - Deadline October 15

Apply Today!

Thanks to a partnership with The Transplantation Society (TTS), this program pairs up emerging transplant centers with established centers so they can benefit from educational support and work together to increase opportunities for kidney transplant patients in low-resource countries.

In the News 



Staff Directory


The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6